Apollomics Inc.
APLMW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001944885
In the last 90 days, Apollomics Inc. insiders filed 3 open-market purchases and 0 sales; 14 institutions reported holding it in 13F filings for Q2 2026, worth $53.6K in total; no superinvestor holds it.
Other share classesAPLM
Q2 2026 vs. Q1 2026
How the institutions holding Apollomics Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 13 | 14 | +1 |
| Shares | 2.44M | 2.71M | +271.7K (+11.1%) |
| Value | $39.0K | $53.6K | +$14.6K (+37.4%) |
New holders (4)
Institutions that held Apollomics Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 594,004 | $11.0K | 0.00% |
| Two Sigma Securities, LLC | 14,412 | $290 | 0.00% |
| Toronto Dominion Bank | 97 | $2 | 0.00% |
| Virtu Financial LLC | 13,229 | $0 | 0.00% |
Sold out (3)
Institutions that held Apollomics Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Susquehanna International Group, LLP | 158,607 | $2.41K |
| Warberg Asset Management LLC | 87,049 | $1.32K |
| SkyView Investment Advisors, LLC | 74,000 | $1.00K |